If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Masaki Kato is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Liver Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Acute Liver Failure Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Interferons Medicine & Life Sciences
Living Donors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2020

  • 3224 Citations
  • 25 h-Index
  • 85 Article
  • 5 Letter
  • 1 Editorial
  • 1 Review article
Hepatocellular Carcinoma
Ribosomal Protein S6

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients

Imoto, K., Kohjima, M., Hioki, T., Kurashige, T., Kurokawa, M., Tashiro, S., Suzuki, H., Kuwano, A., Tanaka, M., Okada, S., Kato, M. & Ogawa, Y., Jan 1 2019, In : Canadian Journal of Gastroenterology and Hepatology. 2019, 6391712.

Research output: Contribution to journalArticle

Open Access
Wounds and Injuries
Immunosuppressive Agents
Chemical and Drug Induced Liver Injury

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: An analysis with real world outcomes from a multicentre cohort in Japan

Igarashi, A., Furusyo, N., Ogawa, E., Nomura, H., Dohmen, K., Higashi, N., Takahashi, K., Kawano, A., Azuma, K., Satoh, T., Nakamuta, M., Koyanagi, T., Kato, M., Shimoda, S., Kajiwara, E. & Hayashi, J., Jun 1 2019, In : BMJ open. 9, 6, e023405.

Research output: Contribution to journalArticle

Open Access
Chronic Hepatitis C
Cost-Benefit Analysis
8 Citations (Scopus)

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study

The Kyushu University Liver Disease Study (KULDS) Group, Jun 2019, In : Hepatology Research. 49, 6, p. 617-626 10 p.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Cohort Studies
Antiviral Agents

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

The Kyushu University Liver Disease Study (KULDS) Group, Jan 1 2019, (Accepted/In press) In : Hepatology Research.

Research output: Contribution to journalArticle

Propensity Score
Virus Diseases